Mark Ramondt
Co-Founder at MultiplAI
A serial (failed) entrepreneur and advisor/mentor to startups with 20+ years of experience in regional and global senior management roles in large multinationals, including more than ten as CFO and driving Open Innovation processes. Passionate about sustainability, innovation, technology, creating the future and enjoying the present with friends, family, and fine food and wine. Adaptability is the key to happiness.
MultiplAI provides a universal remote screening test for complex diseases like cancer. We use a liquid biopsy of whole blood based on RNA sequencing and AI to detect virtually any kind of cancer. It can be used in continuous testing both for preventative screening and post-treatment monitoring. Given that it requires only a simple blood sample, it can be administered remotely, anywhere, and costs a fraction of existing diagnostic methods.